EP1472256 - Bibliographic data
PIPERIDINE DERIVATIVES
Last update | 03/06/2025 |
---|---|
Legal status | Invention expirée |
Origin | Euro-PCT |
(73) Holder |
NERRE THERAPEUTICS LIMITED Stevenage Bioscience Catalyst, Office F25 Incubator Building, Gunnels Wood Road
SG1 2FX s
STEVENAGE HERTS
Royaume-Uni
|
---|---|
(72) Inventors |
ALVARO, Giuseppe GlaxoSmithKline SpA Via Alessandro Fleming 2
I-37135 Verona
Italie
DI FABIO, Romano GlaxoSmithKline SpA Via Alessandro Fleming 2
I-37135 Verona
Italie
TRANQUILLINI, Maria Elvira GlaxoSmithKline SpA Vi a Alessandro Fleming 2
I-37135 Verona
Italie
SPADA, Simone GlaxoSmithKline SpA Via Alessandro Fleming 2
I-37135 Verona
Italie
|
(74) Agent |
Mail recipient Cabinet MURGITROYD 165-169 Scotland Street
G5 8PL
GLASGOW
Royaume-Uni
|
(21) Request number | EP03702621.8 |
---|---|
(22) Request date | 10/02/2003 |
(11) Publication number | EP1472256 |
---|---|
Publication date | 02/11/2005 |
(54) Title of the invention | PIPERIDINE DERIVATIVES |
---|---|
(51) International classification | None |
International classification (before reform) | , , , , , , , |
Claimed priority |
(31) Number: 0203020 |
---|---|
Initial application | None |
Divisional application | EP05077500.6 /EP1666465 None |
Expected annuity | None |
---|---|
Last annuity | Annuity: 20 - Payment date 04/02/2022 |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/4, of 31/12/2005 CESSION - bulletin 2013/3, of 30/09/2013 |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 02/11/2005 Constitution de mandataire pour un dossier - Legal date 09/08/2013 Expiration de l'invention - Legal date 11/02/2023 |